Hyperfine (HYPR) Income from Continuing Operations (2021 - 2026)
Hyperfine's (HYPR) quarterly Income from Continuing Operations came in at 8623000.0 in Q1 2026, up 8.44% YoY from 7951768.73 in Q1 2025, and down 45.86% on a QoQ basis from 5912000.0 in Q4 2025.
Hyperfine (HYPR) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Income from Continuing Operations data on file, last reported at 8623000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 8.44% year-over-year to 8623000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 34779000.0 (up 13.68% YoY) and the FY2025 annual result came in at 35574000.0, up 12.64% from the prior year.
- Income from Continuing Operations declined to 8623000.0 in Q1 2026, from 5912000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 5912000.0 in Q4 2025 to a low of 23775000.0 in Q1 2022.
- A 5-year average of 11901117.65 and a median of 10637000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 205.04% — and 2023, when it surged 54.07%.
- Tracing HYPR's Income from Continuing Operations over 5 years: stood at 13059000.0 in 2022, then gained by 18.19% to 10684000.0 in 2023, then rose by 2.75% to 10390000.0 in 2024, then surged by 43.1% to 5912000.0 in 2025, then slumped by 45.86% to 8623000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 8623000.0 (Q1 2026), 5912000.0 (Q4 2025), and 11019000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Hyperfine | 89.93 Mn | 45.16 Mn | 1.98 Mn | -9.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.30 Mn |
| Mar 31, 2026 | -8.62 Mn |
| Dec 31, 2025 | -5.91 Mn |
| Sep 30, 2025 | -11.02 Mn |
| Jun 30, 2025 | -9.23 Mn |
| Mar 31, 2025 | -9.42 Mn |
| Dec 31, 2024 | -10.39 Mn |
| Sep 30, 2024 | -10.33 Mn |
| Jun 30, 2024 | -10.16 Mn |
| Mar 31, 2024 | -9.85 Mn |
| Dec 31, 2023 | -10.68 Mn |
| Sep 30, 2023 | -10.76 Mn |
| Jun 30, 2023 | -10.64 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | -13.06 Mn |
| Sep 30, 2022 | -13.17 Mn |
| Jun 30, 2022 | -23.16 Mn |
| Mar 31, 2022 | -23.78 Mn |
| Dec 31, 2021 | -26.09 Mn |
| Sep 30, 2021 | -16.39 Mn |